Tengion appoints John Miclot president and CEO
This article was originally published in Scrip
Tengion, a clinical-stage biotech company, has appointed John Miclot president and CEO. Mr Miclot was most recently an executive-in-residence at Warburg Pincus, and prior to that was president and CEO of CCS Medical, a company owned by Warburg Pincus. He served in this role from 2008 until the completion of a financial restructuring of the company in 2010.